FLG and Alzheimer disease: DUPI also increased the expression of FLG, LEKTI (protease inhibitor), and HBD-3 (antimicrobial peptide) after 6‒8 weeks of treatment, as well as the degree of hydration of the stratum corneum, with a consequent improvement in the severity of AD after 12 weeks.